Clinical Trials

Malignant Solid Tumor

NCT06097728 2026-04-02

eVOLVE-Meso

Phase 3 Recruiting

825 enrolled

Phase 1 Active not recruiting

Mesothelioma, Malignant, Mesothelioma

NCT04328844 2026-03-30

A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

210 enrolled

DermatologicLymphoidMyeloidOther solid neoplasmThoracic

Uveal Melanoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Mesothelioma, Primary Myelofibrosis

NCT07466160 2026-03-12

A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors

Phase 1/2 Recruiting

280 enrolled

Solid Tumor

NCT07111546 2026-03-11

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

Phase 2 Recruiting

140 enrolled

Advanced Solid Tumour

NCT07331155 2026-03-09

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

Phase 2 Recruiting

110 enrolled

Advanced Solid Tumour

NCT07381829 2026-02-02

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer

328 enrolled

Advanced Solid Tumor Cancer

NCT05136677 2026-01-23

CheckMate 6DW

102 enrolled

Mesothelioma, Malignant

NCT07268040 2026-01-12

A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors

Phase 2 Recruiting

400 enrolled

Malignant Solid Tumors

NCT06241456 2025-12-09

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

351 enrolled

Advanced Solid Tumor

NCT07256782 2025-12-01

A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

444 enrolled

Advanced Solid Tumor

NCT04047862 2025-08-22

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

446 enrolled 49 charts

Locally Advanced and Metastatic Solid Tumors

NCT03034304 2025-07-24

A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors

Phase 1 Terminated

105 enrolled

Advanced Solid Tumors

NCT04153565 2025-07-17

MK-3475-A17

19 enrolled 14 charts

Phase 1/2 Not yet recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Mesothelioma

NCT06682611 2024-11-12

Safety and Efficacy of SYHA1813 Single Agent or in Combination With Different Regimens in Unresectable Locally Advanced or Metastatic Solid Tumors.

380 enrolled

Unresectable Locally Advanced or Metastatic Solid Tumors

NCT02516813 2024-10-15

Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy

52 enrolled 43 charts

Advanced Solid Tumors

NCT04747470 2024-09-03

Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors

Phase 1 Terminated

13 enrolled 18 charts

Advanced Solid Tumors

NCT03421353 2024-08-21

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

76 enrolled

Advanced Solid Tumours

NCT06332170 2024-07-18

ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid Tumors

610 enrolled

Advanced Solid Tumor

NCT06336707 2024-07-18

HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors

1,048 enrolled

Phase 2 Not yet recruiting

Advanced Solid Tumors

NCT06446388 2024-06-06

Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors

360 enrolled

605 enrolled 17 charts 3 FDA

Advanced Solid Tumor

NCT02899299 2024-05-21

CheckMate743

Phase 3 Completed

Mesothelioma

NCT04934514 2024-02-20

Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors

Phase 1/2 Unknown

97 enrolled

Advanced Solid Tumor

NCT00782574 2023-12-21

Phase I AZD2281/Cisplatin in Advanced Solid Tumour Patients

57 enrolled

Advanced Solid Tumors

NCT06116240 2023-11-03

A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors

Phase 1 Unknown

135 enrolled

Solid Tumor

NCT02709512 2023-10-04

ATOMIC

Phase 2/3 Completed

249 enrolled 17 charts

Mesothelioma, Malignant, Mesothelioma

NCT00648648 2023-09-21

MK-1775-001

206 enrolled 40 charts

Solid Tumors

NCT06041035 2023-09-18

A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

115 enrolled

Solid Tumor

NCT05898451 2023-06-12

R-2

55 enrolled

Solid Tumor

NCT05794477 2023-06-02

A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

132 enrolled

Advanced Solid Tumor

NCT03577704 2023-04-12

HLX07Ib/II

56 enrolled

Advanced Solid Tumors

NCT00738582 2022-09-22

Amatuximab

89 enrolled 12 charts

Mesothelioma, Malignant

NCT02347917 2022-04-12

A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma

28 enrolled 23 charts

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

NCT01655225 2022-04-08

A Study of LY3023414 in Participants With Advanced Cancer

BreastLymphoidOther solid neoplasmThoracic

156 enrolled

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lymphoma, Lymphoma, Non-Hodgkin, Mesothelioma, Neoplasm Metastasis

NCT04802980 2021-07-28

A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor

Phase 1 Unknown

72 enrolled

Solid Tumor

NCT00700336 2021-07-20

Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)

69 enrolled 9 charts

Mesothelioma, Malignant

NCT02715531 2021-07-09

A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors

243 enrolled

Solid Tumor

NCT01675765 2020-09-30

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

60 enrolled 15 charts

Mesothelioma, Malignant, Neoplasms

NCT03920839 2020-04-24

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

Phase 1 Withdrawn

Parkinson Disease 4, Autosomal Dominant Lewy Body, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

NCT02157792 2020-04-01

M6620 First in Human Study

200 enrolled

Advanced Solid Tumor

NCT02357147 2020-03-17

ARTEMIS

Phase 2 Terminated

124 enrolled 10 charts

Severe combined immunodeficiency with sensitivity to ionizing radiation, Mesothelioma, Malignant

NCT02639091 2019-11-07

Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors

36 enrolled

Lung Neoplasms, Mesothelioma

NCT01907100 2019-03-18

Nintedanib (BIBF 1120) in Mesothelioma

Phase 2/3 Terminated

545 enrolled 15 charts

Mesothelioma

NCT02397928 2018-09-25

Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)

82 enrolled

Mesothelioma, Malignant

NCT01139775 2018-05-18

A Study in Non Small Cell Lung Cancer

76 enrolled 24 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung, Mesothelioma

NCT00483093 2014-05-30

Study of NGR-hTNF in Combination With Cisplatin in Solid Tumor

22 enrolled

GenitourinaryOther solid neoplasmThoracic

Solid Tumors

NCT01604863 2012-11-01

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

Phase 1 Suspended

54 enrolled

Lung Neoplasms, Mesothelioma, Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT00528619 2011-04-08

A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors

96 enrolled

Carcinoma, Non-Small-Cell Lung, Mesothelioma, Neoplasms

NCT00116896 2009-01-21

Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors

25 enrolled